News

Nov 22 2018
Toronto - November 22, 2018 - Biosimilars Canada, the national association representing Canada's biosimilar medicines industry, today announced that Innomar Strategies, Canada's leading specialty pharmaceuticals service provider has been selected as the preferred provider for the Biosimilars Canada Patient Support Program (PSP) platform. The platform will provide a common suite of PSP services for Biosimilars Canada members going forward that can be customized to meet the individual needs of the therapy, the biosimilar sponsor and payers.
Read more
January 9, 2017
TORONTO, January 9, 2017 - Jim Keon, President of Biosimilars Canada, issued the following statement regarding the release of the revised Guidance Document, Information and Submission Requirements for Biosimilar Biologic Drugs:
Read more
April 7, 2015
Toronto, April 7, 2015 - The Canadian Generic Pharmaceutical Association (CGPA) announced today the establishment of a new CGPA Biosimilars Board and the election of Michel Robidoux, President and General Manager of Sandoz Canada, as its inaugural Chair.
Read more